LSD and Its Structural Derivatives
Cayman offers authentic lysergamide analytical standards and research compounds for the identification of lysergamide NPS and to aid in research and discovery of these compounds for therapeutic use. LSD was the twenty-fifth compound in a series produced by Dr. Albert Hofmann, a natural products chemist at Sandoz AG Pharmaceutical Company in Swizelrand in 1938, but initial screening failed to reveal any activity of interest. With renewed interest in the potential of psychedelic drugs for the treatment of mental health disorders international research interest in LSD is growing rapidly.
Download this article to find out more about:
- The fundamental chemistry and pharmacology of LSD and related analogs
- The human metabolism of LSD
- The analytical profile of LSD and related analogs